News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Marwan Fakih: Privileged to present R Phase 2 study results of BOT +/- BAL in chemoresistant MSS CRC at ASCO GI25
Marwan Fakih/X
Jan 28, 2025, 17:23

Marwan Fakih: Privileged to present R Phase 2 study results of BOT +/- BAL in chemoresistant MSS CRC at ASCO GI25

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on X:

“Today, at GI ASCO, I had the privilege of presenting the results of R Phase 2 study of BOT +/- BAL in chemoresistant MSS CRC – an area in dire need of treatment options. BOT75/BAL240 ORR 19%, DCR 55%. BAL value confirmed. Majority study responses ongoing. Durable responses matter.”

Marwan Fakih: Privileged to present R Phase 2 study results of BOT +/- BAL in chemoresistant MSS CRC at ASCO GI25

More posts featuring Marwan Fakih.

ASCO GI 25 cancer colorectal cancer Marwan Fakih MSS CRC OncoDaily Oncology
Special Coverage
Blog
Jun 26, 2025, 19:30
Getting Ready to Make the Most of Upcoming Events - EORTC
Blog
Jun 26, 2025, 19:22
Tobacco Taxation Gains Momentum in Kenya and Uganda Through Civil Society Mobilisation - UICC
Blog
Jun 26, 2025, 18:56
Late Breaking Abstract Submission Is Open - European Association of Neuro-Oncology
Blog
Jun 26, 2025, 18:44
Winan van Houdt: Pleased to Be Invited to the First Colombian Conference of Surgical Oncology
Positive
Jun 26, 2025, 18:34
Improving Life After Cancer for Survivors of Childhood and Adolescent Cancer - SIOP Europe
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski